GlassScriptPhysician profile
Christopher H Alexander
NPI 1013149954
$5,575.80
in general payments reported to CMS, 2019-2025
38 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,241 · 2022: $1,015 · 2023: $960 · 2024: $610 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,320.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $824.13 | 2021-2025 | Esprit, Aveir, Jot Dx |
| Amgen INC. | $572.11 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $473.74 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $407.62 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $384.68 | 2021-2024 | Farxiga |
| Medtronic, INC. | $377.66 | 2021-2025 | Symplicity G3, Linq II |
| Kestra Medical Technology Services, INC. | $338.66 | 2022-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $324.30 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $234.45 | 2021-2025 | Verquvo |
| Bard Peripheral Vascular, INC. | $159.82 | 2025 | Venovo |
| Endologix LLC | $148.27 | 2025 | Endocross Device, Torus Stent Graft System |
| Pfizer INC. | $142.36 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $140.59 | 2021-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.85 | 2021-2025 | Jardiance |
| Scpharmaceuticals INC. | $100.42 | 2023-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.